According to bluebird bio
's latest financial reports the company has $0.22 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $0.19 B | -47.54% |
2021-12-31 | $0.37 B | -72.38% |
2020-12-31 | $1.35 B | 5.45% |
2019-12-31 | $1.28 B | -31.83% |
2018-12-31 | $1.88 B | 16.12% |
2017-12-31 | $1.62 B | 86.72% |
2016-12-31 | $0.86 B | 2.23% |
2015-12-31 | $0.85 B | 73.13% |
2014-12-31 | $0.49 B | 223.91% |
2013-12-31 | $0.15 B | -372.06% |
2012-12-31 | $-55.75 M | 0.07% |
2011-12-31 | $-55.71 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Sanofi SNY | $82.20 B | 36,839.37% | ๐ซ๐ท France |
Merck MRK | $40.42 B | 18,065.15% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $56.69 M | -74.52% | ๐บ๐ธ USA |
GlycoMimetics
GLYC | $28.91 M | -87.01% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $5.07 B | 2,180.00% | ๐บ๐ธ USA |